At the same time, combined ratio for Non-Life improved to 93.0% (2021: 93.9%) despite the claims from February's storm of EUR 100 million after reinsurance.
"We have had an eventful year, one that was overshadowed by the war in Ukraine. First and foremost, this sadly led to enormous human suffering. Partly driven by the war, 2022 was an extreme year in many other respects as well with rising energy prices, soaring inflation, higher interest rates and lower equity prices. This had an impact on our operational result, which decreased to EUR 174 million. Underlying we accomplished our strategic goals. Gross premium income increased by more than 5%, whilst expenses only increased by 2%. Our solvency position remains robust at 209%. Furthermore, our Health business performed well and Non-Life earned a solid insurance result. The latter resulted in an improved Combined Ratio to 93.0%", said Bianca Tetteroo, Chair of the Executive Board.
Click here for more details.
1836 views